Xtandi (Enzalutamide) is a targeted hormonal therapy used in the treatment of advanced prostate cancer. It works by blocking the effect of male hormones that help cancer cells grow.
What is Xtandi (Enzalutamide)?
Xtandi belongs to a class of drugs known as Androgen Receptor Inhibitors.
Prostate cancer heavily depends on male hormones such as testosterone for growth and progression. Xtandi works by:
- Blocking the effect of male hormones on cancer cells
- Slowing tumor growth and spread
- Improving disease control in advanced cases
In simple terms:
It prevents cancer cells from using male hormones to grow.
Indications
Xtandi (Enzalutamide) is used in:
- Advanced prostate cancer
- Metastatic prostate cancer
- Cases resistant to conventional hormonal therapy
Dosage and Administration
- Dose depends on the treatment protocol
- Taken orally
- Usually once daily
- Can be taken with or without food
- Should be taken consistently at the same time every day
Common Side Effects
May include:
- Fatigue
- High blood pressure
- Headache
- Dizziness
- Joint or muscle pain
- Hot flashes
Rarely: seizures or other complications requiring close monitoring.
Monitoring During Treatment
Patients on Xtandi (Enzalutamide) require:
- Monitoring of treatment response
- Blood pressure checks
- Assessment of general symptoms
- Regular laboratory tests and follow-up
Availability & How to Access Treatment
Xtandi (Enzalutamide) is available through Macrocare’s approved partners.
You can now request and access the medication easily through us.
📩 WhatsApp contact for medication requests:
Click here
Xtandi (Enzalutamide) Xtandi (Enzalutamide) 40 mg is an effective hormonal therapy for advanced prostate cancer that works by blocking the effect of male hormones to help control disease progression.
Medical Disclaimer:
This content is for educational purposes only and does not replace professional medical advice. Treatment decisions should always be made by a qualified physician.
